Our Intellectual Property Litigation practice focuses on the prosecution and defense of intellectual property infringement, misuse, dilution and unfair competition claims. Our intellectual property litigation attorneys are proud to call themselves trial attorneys. They have extensive experience in core technical sciences, intellectual property theories, commercial relationships and economics. They prepare intellectual property litigation strategies in close association with our patent, trademark, copyright, antitrust, franchise and technology attorneys.

As trial advocates, our intellectual property trial attorneys have successfully prosecuted and defended infringement, misappropriation and unfair competition claims before:

  • U.S. Patent and Trademark Office
  • International Trade Commission
  • U.S. Customs Service
  • Federal Trade Commission
  • Food and Drug Administration
  • World Intellectual Property Organization Arbitration and Mediation Forum
  • Trademark Trial and Appeal Board
  • U.S. District Courts and Circuit Courts of Appeal
  • U.S. Supreme Court

We have one of the premier ANDA/generic drug patent litigation practices in the country. We have a proven record of success in these cases having successfully invalidated Pfizer’s patent directed to its multi-billion dollar drug Norvasc(r). We also were successful in knocking out Daiichi Sankyo Co., Ltd.’s patent on Floxin(r) otic, in a case that resulted in a $5 million award to our generic client. Our attorneys have handled or are presently handling several major ANDA litigations, including cases involving Plavix(r), Abilify(r), Uroxatral(r), Boniva(r), Eloxatin(r), Ultracet(r), Wellbutrin XL(r), Strattera(r), Adderall XR(r), Clarinex(r), Amrix(r), Enablex(r), and Cymbalta(r). We also have experience in related FDA and regulatory matters involving marketing approval for generic drugs under the Hatch-Waxman Act. This experience and understanding of the Hatch-Waxman regulatory scheme is critical in crafting successful patent litigation strategy.

We have more than 90 attorneys dedicated to intellectual property and technology law, including patents, trademarks, copyrights, unfair competition, trade secrets, advertising, licensing, e-commerce, entertainment and media, and intellectual property litigation. We have represented multi-national and middle-market corporations in patent, trademark and other intellectual property matters across the country.